Caribe Holdings Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CARIBE HOLDINGS, and what generic and branded alternatives to CARIBE HOLDINGS drugs are available?
CARIBE HOLDINGS has two approved drugs.
Summary for Caribe Holdings
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
Drugs and US Patents for Caribe Holdings
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caribe Holdings | DOXYCYCLINE HYCLATE | doxycycline hyclate | TABLET;ORAL | 062269-002 | Nov 8, 1982 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ||||
| Caribe Holdings | GEMFIBROZIL | gemfibrozil | TABLET;ORAL | 078012-001 | Mar 26, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Caribe Holdings | DOXYCYCLINE HYCLATE | doxycycline hyclate | TABLET;ORAL | 062269-003 | Oct 5, 1983 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
